Peter Covens

Peter Covens is a researcher at Vrije Universiteit Brussel (Brussels, Belgium) specializing in nuclear medicine, radiation protection, and dosimetry. His work focuses on optimizing radiopharmaceutical production (e.g., Astatine-211), advancing computational frameworks for nuclear dose assessment, and analyzing radiation effects in preclinical models. He leads projects like Exploit-PeptIT (peptide-based imaging/therapy) and collaborates with EURADOS-EANM on radiation safety standards.

• Key research areas: Nuclear medicine, radiation dosimetry, and radiochemistry
• Supervises Master's theses on topics like extremity dosimetry and radiopharmaceutical optimization
• Active in conferences/workshops (e.g., 2024 presentation on Astatine-211 accessibility)
• Contributes to European radiation safety policies and clinical dosimetry protocols